Siolta Therapeutics

Developing live biotherapeutics to prevent and treat diseases of high unmet medical need. We leverage our deep knowledge of the human microbiome and its regulatory and developmental functions to develop live biotherapeutic products (LBPs) and diagnostics for the prevention and treatment of a wide range of diseases. Our research and development focus on diseases in the “maternal-infant axis”, including atopic diseases, women’s health, and rare pediatric indications, with limited treatment options.